HPV-Negative Cervical Cancer: A Narrative Review
Open Access
- 26 May 2021
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 11 (6) , 952
Abstract
Cervical cancer (CC) is the fourth most frequent cancer in women worldwide. HPV infection is associated with the majority of CC cases, but a small proportion of CCs actually test negative for HPV. The prevalence of HPV among CC histotypes is very different. It has been suggested that HPV-negative CC may represent a biologically distinct subset of tumors, relying on a distinct pathogenetic pathway and carrying a poorer prognosis, than HPV-positive CCs. Although, the discordance in terms of sensitivity and specificity between different HPV tests as well as the potential errors in sampling and storing tissues may be considered as causes of false-negative results. The identification of HPV-negative CCs is essential for their correct management. The aim of this narrative review is to summarize the clinical and pathological features of this variant. We also discuss the pitfalls of different HPV tests possibly leading to classification errors.Keywords
This publication has 74 references indexed in Scilit:
- High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomasLaboratory Investigation, 2014
- Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancerClinics, 2013
- Nucleic Acid Tests for the Detection of Alpha Human PapillomavirusesVaccine, 2012
- Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vaginaGynecologic Oncology, 2012
- Discrimination of ‘Driver’ and ‘Passenger’ HPV in Tonsillar Carcinomas by the Polymerase Chain Reaction, Chromogenic In Situ Hybridization, and p16INK4a ImmunohistochemistryHead and Neck Pathology, 2011
- Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervixGynecologic Oncology, 2011
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- CHAPTER 7 Methods for detection of HPV infection and its clinical utilityInternational Journal of Gynecology & Obstetrics, 2006
- Neoadjuvant chemotherapy in cervical cancer: a 67 patients experienceInternational Journal of Gynecological Cancer, 2006